Sign inGet started

Adams Helen C.

Insider CIK 1488486 · RXDX Director · IMMX Director · LRAD Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
IMMX Immix Biopharma, Inc. A Award deriv2026-05-222026-05-2912,500— $012,500SEC↗
IMMX Immix Biopharma, Inc. A Award2026-05-222026-05-296,250— $0181,004SEC↗
IMMX Immix Biopharma, Inc. A Award deriv2025-06-202025-06-2333,000— $033,000SEC↗
IMMX Immix Biopharma, Inc. A Award deriv2024-06-112024-06-2133,000— $033,000SEC↗
IMMX Immix Biopharma, Inc. A Award2024-05-202024-05-2074,241— $0174,754SEC↗
IMMX Immix Biopharma, Inc. A Award2024-05-152024-05-2087,740— $0100,740SEC↗
IMMX Immix Biopharma, Inc. P Buy2023-09-122023-09-1413,000$2.96 $38.5K13,000SEC↗
IMMX Immix Biopharma, Inc. A Award deriv2023-08-112023-08-1420,000— $020,000SEC↗
RXDX Prometheus Biosciences, In D To issuer deriv2023-06-162023-06-1630,000— $00SEC↗
RXDX Prometheus Biosciences, In D To issuer deriv2023-06-162023-06-161,083— $00SEC↗
RXDX Prometheus Biosciences, In D To issuer deriv2023-06-162023-06-1621,526— $00SEC↗
RXDX Prometheus Biosciences, In D To issuer2023-06-162023-06-162,674— $00SEC↗
RXDX Prometheus Biosciences, In A Award2023-05-192023-05-192,174— $02,674SEC↗
IMMX Immix Biopharma, Inc. A Award deriv2022-07-142022-07-1816,000— $053,500SEC↗
RXDX Prometheus Biosciences, In A Award deriv2022-05-192022-05-2021,526— $021,526SEC↗
RXDX Prometheus Biosciences, In A Award deriv2021-11-142021-11-161,083— $01,083SEC↗
RXDX Prometheus Biosciences, In P Buy2021-03-162021-03-16500$19.00 $9.5K500SEC↗
LRAD LRAD Corp A Award deriv2012-05-102012-05-1025,000— $025,000SEC↗